Cyst fluid carcinoembryonic antigen concentration and cytology by endosonography-guided fine needle aspiration in predicting malignant pancreatic mucinous cystic neoplasms

Journal of Digestive Diseases

Volumn 14, Issue 4, 2013, Pages 191-195

  Zhan, Xian Bao ^a   Wang, Bin ^a   Liu, Feng ^a   Ye, Xiao Fei ^b   Jin, Zhen Dong ^a   Li, Zhao Shen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Carcinoembryonic antigen; Cytology; Endosonography; Fine needle biopsy; Mucinous cystic neoplasm; Pancreatic neoplasms

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CYST FLUID; CYTOLOGY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE BIOPSY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MALIGNANT NEOPLASTIC DISEASE; MUCINOUS CYSTIC NEOPLASM; PANCREAS SURGERY; PRECANCER; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

AGED; BIOPSY, FINE-NEEDLE; CARCINOEMBRYONIC ANTIGEN; CYST FLUID; CYSTADENOCARCINOMA, MUCINOUS; DIAGNOSIS, DIFFERENTIAL; ENDOSONOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84875619804     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/1751-2980.12027     Document Type: Article

References (19)

1. Longnecker DS, Adler G, Hruban RH, Klöppel G. Intraductal papillary-mucinous neoplasms of the pancreas. In: Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumors of the Digestive System. Lyons: IARC Press, 2000; 237-241.
2. Compagno J, Oertel JE. Mucinous cystic neoplasms of the pancreas with overt and latent malignancy (cystadenocarcinoma and cystadenoma). A clinicopathologic study of 41 cases. Am J Clin Pathol 1978; 69: 573-580.
3. Brugge WR, Lewandrowski K, Lee-Lewandrowski E etal. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004; 126: 1330-1336.
4. Sreenarasimhaiah J, Lara LF, Jazrawi SF, Barnett CC, Tang SJ. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts. JOP 2009; 10: 163-168.
5. Buscaglia JM, Giday SA, Kantsevoy SV etal. Patient- and cyst-related factors for improved prediction of malignancy within cystic lesions of the pancreas. Pancreatology 2009; 9: 631-638.
6. Wu H, Cheng NS, Zhang YG, Luo HZ, Yan LN, Li J. Improved early diagnosis of cystadenocarcinoma of the pancreas. Hepatobiliary Pancreat Dis Int 2007; 6: 87-91.
7. Linder JD, Geenen JE, Catalano MF. Cyst fluid analysis obtained by EUS-guided FNA in the evaluation of discrete cystic neoplasms of the pancreas: a prospective single-center experience. Gastrointest Endosc 2006; 64: 697-702.
8. Shami VM, Sundaram V, Stelow E etal. The presence of mucin as a predictor of malignancy in pancreatic cystic neoplasia. Gastrointest Endosc 2006; 63: AB 277.
9. Masci E, Mariani A, Curioni S, Testoni PA. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy 2003; 35: 830-834.
10. Lai R, Stanley MW, Bardales R, Linzie B, Mallery S. Endoscopic ultrasound-guided pancreatic duct aspiration: diagnostic yield and safety. Endoscopy 2002; 34: 715-720.
11. Frossard JL, Amouyal P, Amouyal G etal. Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions. Am J Gastroenterol 2003; 98: 1516-1524.
12. Grobmyer SR, Cance WG, Copeland EM, Vogel SB, Hochwald SN. Is there an indication for initial conservative management of pancreatic cystic lesions? J Surg Oncol 2009; 100: 372-374.
13. van der Waaij LA, van Dullemen HM, Porte RJ. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest Endosc 2005; 62: 383-389.
14. Reddy RP, Chari ST, Smyrk TC etal. Sensitivity and specificity of suggested diagnostic cutoffs for pancreatic cyst fluid CEA to diagnose cystic lesions of the pancreas. Gastrointest Endosc 2006; 63: AB 268.
15. Jimenez RE, Warshaw AL, Z'graggen K etal. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy. Ann Surg 1999; 230: 501-511.
16. Sasaki S, Yamamoto H, Kaneto H etal. Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas. Oncol Rep 2003; 10: 21-25.
17. Khalid A, Zahid M, Finkelstein SD etal. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointest Endosc 2009; 69: 1095-1102.
18. Tanaka M, Chari S, Adsay V etal; International Association of Pancreatology. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006; 6: 17-32.
19. Reddy RP, Smyrk TC, Zapiach M etal. Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer. Clin Gastroenterol Hepatol 2004; 2: 1026-1031.